Cargando…
Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells
A major contributing factor in triple-negative breast cancer progression is its ability to evade immune surveillance. One mechanism for this immunosuppression is through ribosomal protein S19 (RPS19), which facilitates myeloid-derived suppressor cells (MDSCs) recruitment in tumors, which generate cy...
Autores principales: | Gupta, Nehal, Gaikwad, Shreyas, Kaushik, Itishree, Wright, Stephen E., Markiewski, Maciej M., Srivastava, Sanjay K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152242/ https://www.ncbi.nlm.nih.gov/pubmed/34068008 http://dx.doi.org/10.3390/ijms22105150 |
Ejemplares similares
-
Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis
por: Gupta, Nehal, et al.
Publicado: (2021) -
Pimozide Suppresses the Growth of Brain Tumors by Targeting STAT3-Mediated Autophagy
por: Ranjan, Alok, et al.
Publicado: (2020) -
Role of Phytochemicals in Cancer Prevention
por: Ranjan, Alok, et al.
Publicado: (2019) -
Antimalarial pharmacology and therapeutics of atovaquone
por: Nixon, Gemma L., et al.
Publicado: (2013) -
Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa
por: Manzanares, Laura D., et al.
Publicado: (2022)